Abstract:BackgroundLead (Pb) exposure impairs cognitive functions of children. Whether Pb exposure in different developmental stages induces long-term cognitive impairment, and whether chelation therapy could mitigate the cognitive impairment is rarely reported.ObjectiveThis experiment is designed to investigate effects of Pb exposure and chelation therapy during different developmental stages (breastfeeding, weaning, and early puberty periods) on mouse short-term and long-term cognitive functions.MethodsC57BL/6 male mice in breastfeeding period, weaning period, and early puberty period (postnatal day 2, 21, and 41; PND 2, PND 21, and PND 41, n=30, respectively) were randomly divided into control, Pb exposure, and Pb+dimercaptosuccinic acid (DMSA) treatment groups (n=10 in each group). The control groups received standard food and deionized water. The Pb exposure mice received standard food and free drinking water containing Pb acetate (0.1% for dams, and 0.05% for pups). After receiving Pb acetate for 19 d, the Pb+DMSA treatment groups were given 1 mmol·kg−1·d−1 DMSA for 6 d with gastric infusion. Whole blood Pb levels were measured after DMSA treatment on experimental day 25. The effects on short-term cognitive function were tested in the Morris Water Maze task by the analyses of escape latency on PND 75−79, as well as target quadrant time and times of platform-crossing on PND 80. Hippocampal long-term potentiation of field excitatory postsynaptic potential (fEPSP) of mice on PND 365 was induced to demonstrate the effects on long-term cognitive function.ResultsThe blood Pb levels among the Pb, Pb+DMSA, and control groups were statistically different for each developmental stage (Fbreastfeeding period=43.47, Fweaning period=228.6, Fearly period of puberty=274.2, all P<0.001). Compared to the counterpart control groups, blood Pb levels of the pb exposure groups (386.4, 265.0, and 178.1 μg·L−1 in breastfeeding period, weaning period, and early puberty period, respectively) were significantly higher for all stages. After the chelation therapy, the blood Pb significantly decreased for all stages (28.68, 47.29, and 20.93 μg·L−1 in the three periods, respectively, all P<0.001) and the Pb levels of the mice exposed in the breastfeeding period decreased most (by 92.58%, 82.15%, and 88.25% in the three periods, respectively, P<0.01). In the water maze task, the mice exposed to Pb in the breastfeeding period had a gentler decrease in escape latency (from 54.20 s on day 1 to 30.54 s on day 5, by 43.65 % decrease) than the control group (from 32.44 s on day 1 to 15.20 s on day 5, by 53.14 % decrease) (P<0.01) and a significant decrease in target quadrant time (P<0.05). After the chelation therapy, the escape latency of the DMSA-treated mice in the breastfeeding period (from 40.94 s on day 1 to 20.87 s on day 5, by 48.99 % decrease) was steeper than that of the Pb-exposed mice (P<0.05). The differences in the escape latency, target quadrant time, and times of platform-crossing were not significant between the Pb-exposed mice and the control mice in the weaning period and early period of puberty (all P>0.05). After the chelation therapy, such differences were also not significant compared with before therapy. Due to the small sample size, data were merged for different developmental stages in the long-term potentiation test. The amplitudes of fEPSP induced in the control, Pb-exposed, and DMSA treatment groups were significantly different (Fgroups=212.2, Ftime=11.36. P<0.001). The average fEPSP amplitude induced in the last 10 min recorded in the hippocampal slices in the Pb exposure group was significantly lower than that in the control group (P<0.05). After the DMSA treatment, no significant differences were observed in the fEPSP amplitudes between the Pb exposure group and the DMSA treatment group (P>0.05). When observing the fEPSP data by developmental stages, the fEPSP amplitude in the breastfeeding Pb-exposure group was 27.2% lower than that of the breastfeeding control group, while such changes were not obvious in the weaning period or in the early period of puberty. The fEPSP amplitude in breastfeeding DMSA treatment group was 44.3% higher than that of the breastfeeding Pb exposure group, while such changes were not observed in the weaning period or in early period of puberty.ConclusionPb exposure during different developmental stages, especially in breastfeeding period, could affect short-term and long-term cognitive functions of mice. The harmful effects may be partially reversed by DMSA chelation therapy, especially being treated in breastfeeding period.

The Effect of Sodium Selenite on Lead Induced Cognitive Dysfunction

Study on the Neurotoxic Effects of Low-Level Lead Exposure in Rats

Possible role of selenium in ameliorating lead-induced neurotoxicity in the cerebrum of adult male rats: an experimental study

Selenium against lead-induced apoptosis in chicken nervous tissues via mitochondrial pathway.

Molecular Mechanisms of Selenium Mitigating Lead Toxicity in Chickens Via Mitochondrial Pathway: Selenoproteins, Oxidative Stress, HSPs, and Apoptosis

S-Adenosyl-L-Methionine Improves Impaired Hippocampal Long-Term Potentiation And Water Maze Performance Induced By Developmental Lead Exposure In Rats

Molecular Mechanism of Selenium Against Lead-Induced Apoptosis in Chicken Brainstem Relating to Heat Shock Protein, Selenoproteins, and Inflammatory Cytokines

[Protection Effects of S-adenosyl-L-methionine on Lead-Exposed Rats During Development and Its Mechanism of Long-Term Potentiation].

Activation of Nrf2 by lead sulfide nanoparticles induces impairment of learning and memory

Selenoproteins and Heat Shock Proteins Were Involved in Molecular Mechanism of Selenium Alleviated Oxidative Stress-Mediated Apoptosis Caused by Lead Poisoning Via Mitochondrial Pathway in Chicken Cerebellums and Thalami

Effect of lead sulfide nanoparticles exposure on calcium homeostasis in rat hippocampus neurons

Molecular Mechanisms of Lead-Induced Changes of Selenium Status in Mice Livers Through Interacting with Selenoprotein P.

Effects of Lead Exposure and Chelation Therapy in Different Developmental Stages on Mouse Short-Term and Long-Term Cognitive Functions

Selection of nutrients for prevention or amelioration of lead-induced learning and memory impairment in rats.

Studies of Effects of Zinc and Selenium on Lead-Induced Auditory Changes

Effects of Lead on Rat Behavior and Activity of Extracellular Signal Regulated Kinase 2 of Hippocampus CA1 Region

Effects of prenatal exposure to stress and lead on spatial learning and memory development in rats

Selenium protects against Pb-induced renal oxidative injury in weaning rats and human renal tubular epithelial cells through activating NRF2

The Effects of Meso-2,3-dimercaptosuccinic Acid and Oligomeric Procyanidins on Acute Lead Neurotoxicity in Rat Hippocampus.

Anti-inflammatory effect of selenium on lead-induced testicular inflammation by inhibiting NLRP3 inflammasome activation in chickens

Maternal low-level lead exposure reduces the expression of PSA-NCAM and the activity of sialyltransferase in the hippocampi of neonatal rat pups.